WallStSmart
VBIV

VBI Vaccines Inc

NASDAQ: VBIV · HEALTHCARE · BIOTECHNOLOGY

$0.07
+0.00% today

Updated 2026-04-30

Market cap
$1.87M
P/E ratio
P/S ratio
0.20x
EPS (TTM)
$-3.54
Dividend yield
52W range
$0 – $0
Volume

VBI Vaccines Inc (VBIV) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item20042005200620072008200920102011201220132014201520162017201820192020202120222023
Operating cash flow$-185608.00$-300230.00$-192615.00$-273414.00$-518215.00$-438038.00$-438038.00$-1.08M$-14.21M$-6.46M$-4.93M$-9.05M$-18.52M$-31.38M$-45.53M$-48.71M$-47.05M$-39.91M$-73.69M$-60.88M
Capital expenditures$0.00$1911.00$220147.00$403350.00$285796.00$1.70M$1.70M$7.79M$89441.00$2.08M$1.96M$549000.00$585000.00$640000.00$5.99M$3.67M$1.00M$2.00M$4.34M$867000.00
Depreciation
Stock-based comp$10358.00$233319.00$233319.00$16.06M$251658.00$1.01M$1.05M$2.13M$2.52M$2.41M$3.31M$3.94M$5.29M$9.63M$9.70M$6.66M
Free cash flow$-185608.00$-302141.00$-412762.00$-676764.00$-804011.00$-2.14M$-2.14M$-8.87M$-14.30M$-8.54M$-6.89M$-9.60M$-19.10M$-32.02M$-51.53M$-52.38M$-48.05M$-41.90M$-78.04M$-61.75M
Investing cash flow
Financing cash flow
Dividends paid$0.00$0.00
Share repurchases
Debt repayment
Net change in cash$19.81M$35.41M$-7.91M$-14.97M$49.34M$27.54M$-58.59M